PriceTargets.com logo

Seer - SEER Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $3.00
  • Forecasted Upside: 33.33%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.25 As of 12/23/2024 06:26 PM ET
▼ -0.06 (-2.60%)

This chart shows the closing price for SEER by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Seer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SEER and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SEER

Analyst Price Target is $3.00
▲ +33.33% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Seer in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 33.33% upside from the last price of $2.25.

This chart shows the closing price for SEER for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Seer. This rating has held steady since December 2023, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
7/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
9/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
12/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/13/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$7.00 ➝ $3.00
3/5/2024Morgan StanleyReiterated RatingEqual Weight$7.00
2/21/2023Morgan StanleyLower TargetEqual Weight$11.00 ➝ $10.00
1/4/2023Bank of AmericaDowngradeNeutral ➝ Underperform$9.00 ➝ $6.50
11/10/2022Morgan StanleyLower TargetEqual Weight$14.00 ➝ $11.00
8/11/2022Morgan StanleyLower TargetEqual Weight$19.00 ➝ $14.00
8/11/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$20.00 ➝ $12.00
3/1/2022Morgan StanleyLower TargetEqual Weight$23.00 ➝ $21.00
2/15/2022Morgan StanleyLower TargetEqual Weight$46.00 ➝ $23.00
10/15/2021CowenInitiated CoverageOutperform
8/13/2021Morgan StanleyLower TargetEqual Weight$55.00 ➝ $50.00
5/12/2021Morgan StanleyLower TargetEqual Weight$60.00 ➝ $55.00
3/30/2021Morgan StanleyLower TargetEqual Weight$65.00 ➝ $60.00
12/29/2020Morgan StanleyInitiated CoverageEqual Weight$65.00
12/29/2020CowenInitiated CoverageOutperform
12/29/2020Bank of AmericaInitiated CoverageNeutral$69.00
12/29/2020JPMorgan Chase & Co.Initiated CoverageOverweight$75.00
(Data available from 12/23/2019 forward)

News Sentiment Rating

-0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
5/27/2024
  • 4 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/26/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
7/26/2024
  • 2 very positive mentions
  • 25 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Mentions as of
8/25/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
Mentions as of
9/24/2024
  • 1 very positive mentions
  • 19 positive mentions
  • 3 negative mentions
  • 6 very negative mentions
Mentions as of
10/24/2024
  • 1 very positive mentions
  • 19 positive mentions
  • 5 negative mentions
  • 3 very negative mentions
Mentions as of
11/23/2024
  • 0 very positive mentions
  • 17 positive mentions
  • 6 negative mentions
  • 5 very negative mentions
Mentions as of
12/23/2024

Current Sentiment

  • 0 very positive mentions
  • 17 positive mentions
  • 6 negative mentions
  • 5 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Seer logo
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Read More

Today's Range

Now: $2.25
Low: $2.25
High: $2.33

50 Day Range

MA: $2.24
Low: $1.84
High: $2.55

52 Week Range

Now: $2.25
Low: $1.51
High: $2.63

Volume

147,030 shs

Average Volume

423,257 shs

Market Capitalization

$132.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Seer?

The following sell-side analysts have issued reports on Seer in the last year: Morgan Stanley.
View the latest analyst ratings for SEER.

What is the current price target for Seer?

0 Wall Street analysts have set twelve-month price targets for Seer in the last year. Their average twelve-month price target is $3.00, suggesting a possible upside of 33.3%. Morgan Stanley has the highest price target set, predicting SEER will reach $3.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $3.00 for Seer in the next year.
View the latest price targets for SEER.

What is the current consensus analyst rating for Seer?

Seer currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SEER, but not buy more shares or sell existing shares.
View the latest ratings for SEER.

What other companies compete with Seer?

Other companies that are similar to Seer include EyePoint Pharmaceuticals, Aehr Test Systems, Quanterix, Senseonics and Nautilus Biotechnology. Learn More about companies similar to Seer.

How do I contact Seer's investor relations team?

The company's listed phone number is 650-453-0000 and its investor relations email address is [email protected]. The official website for Seer is www.seer.bio. Learn More about contacing Seer investor relations.